YesIam
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This will run toward close and big bounce on Monday as message spread over the weekend. This is a replacement of vaccine who do not want to have it due to other reasons.
Yes. Agreed.
This is going cross 20+ by tomorrow due to lots of shorting.
Concert Pharma Stock Surges On $65M Financing From Healthcare Funds
Benzinga · 11/04/2021 08:48
Concert Pharmaceuticals Inc (NASDAQ:CNCE) has agreed with BVF Partners L.P. and RA Capital Management to raise gross proceeds of $65 million.
In addition, Concert will potentially receive an additional $103 million upon the full exercise of warrants being issued in connection with the agreement.
The financing will close by November 5.
With the $65 million financing, Concert now expects to fund its operations into the fourth quarter of 2022.
Related Link: Concert Pharma Sees US Application Submission For Patchy Hair Loss Candidate In 2023.
The financing consists of selling common and preferred stock, warrants, and a portion of Concert's right to receive potential future AVP-786 royalties under an existing licensing agreement with Avanir Pharmaceuticals Inc (Avanir).
As part of the financing, BVF and RA will receive an aggregate of 16.25 million common stock equivalents, warrants to purchase up to 8.125 million shares at an exercise price of $5.34 per share, and warrants to purchase up to 8.125 million shares at $7.35 per share.
Price Action: CNCE shares are up 26% at $3.63 during the premarket session on the last check Thursday.
There has to be some reason why they are paying more than market price for offering. I believe this will go up from here. It bottomed out. There will be follow-up news once offering is closed. Also, they is no risk of dilution until end of 2022 since they will have enough money to conduct trial.
CSNE has consolidated between 3.56 and 3.65. It is going to go up from here and will cross 52 week high tomorrow after they close offering tomorrow.
CNCE is flying.
Concert Pharmaceuticals Inc (NASDAQ: CNCE) has agreed with BVF Partners L.P. and RA Capital Management to raise gross proceeds of $65 million.
In addition, Concert will potentially receive an additional $103 million upon the full exercise of warrants being issued in connection with the agreement.
The financing will close by November 5.
With the $65 million financing, Concert now expects to fund its operations into the fourth quarter of 2022.
Related Link: Concert Pharma Sees US Application Submission For Patchy Hair Loss Candidate In 2023.
The financing consists of selling common and preferred stock, warrants, and a portion of Concert's right to receive potential future AVP-786 royalties under an existing licensing agreement with Avanir Pharmaceuticals Inc (Avanir).
As part of the financing, BVF and RA will receive an aggregate of 16.25 million common stock equivalents, warrants to purchase up to 8.125 million shares at an exercise price of $5.34 per share, and warrants to purchase up to 8.125 million shares at $7.35 per share.
Yes. I say earning report. It's improving year over year. Also, this has less outstanding shares compared to PETX. This should be much much higher than PETX(at least more than double price of PETX).
I believe this going up since PETZ went up by 200+% up in afterhours. I think this will go up by more than 100% tomorrow.
I believe some news coming. 10% up during after hour with 500K+ volume.
Why are you buying now? Are you expecting any news tomorrow?
Why is it moving?
Breaking news.
Bharat Biotech's Covaxin gets WHO approval
WHO approval is available on https://www.freepressjournal.in/ site at home page. it's a big headline.
Shorties are going to get into trouble now. It is going to go above $25 before market open.
After a much wait, the World Health Oganisation on Wednesday recommended Bharat Biotech's COVID-19 vaccine Covaxin, according to a PTI report.
The World Health Organization technical committee today met for a decision on giving an emergency use listing (EUL) to Covaxin, which amounted to a recognition and helped pave the way for people who have taken the dose to qualify for vaccine mandates in other countries.
Bharat Biotech had been stuck in a regulatory loop, with independent technical experts of the UN health body taking longer to analyse the data that previously disclosed timelines.
The WHO is in the process of evaluating Covaxin's clinical trial data for use of EUL.
The TAG on October 26 had sought "additional clarifications" from the company for Covaxin to conduct a final "risk-benefit assessment" for Emergency Use Listing of the vaccine.
"The Technical Advisory Group of WHO has recommended Emergency Use Listing status for Covaxin," a source told PTI.
The TAG-EUL is an independent advisory group that provides recommendations to WHO on whether a COVID-19 vaccine can be listed for emergency use under the EUL procedure.
Covaxin has demonstrated 77.8 per cent effectiveness against symptomatic COVID-19 and 65.2 per cent protection against the new Delta variant.
In June, the company said it concluded the final analysis of Covaxin efficacy from Phase 3 trials.
Bharat Biotech's Covaxin and AstraZeneca and Oxford University's Covishield are the two widely used vaccines in India.
Finally, we got WHO approval.
COVID-19: Bharat Biotech's Covaxin gets WHO technical team recommendation for emergency use listing
https://www.freepressjournal.in/india/covid-19-bharat-biotechs-covaxin-gets-who-approval
Ocugen Partner Bharat Biotech Tweeted: The CDSCO (Central Drugs Standard Control Organisation) has Approved the Extension of Shelf Life of Covaxin Up to 12 Months from Date of Manufacture
#COVAXIN #COVID19 #BharatBiotech pic.twitter.com/9oPnYnlgtC
— Bharat Biotech (@BharatBiotech) November 3, 2021
Did we got an approval?
It's green now. What is going on now?
They are confident to get an approval from WHO. Once they they have an approval then stock will skyrocket and they will do offering but not at this stage.
TAG had sought gender-wise immunogenicity data for the vaccine in the use of adults over the age of 60, The Economic Times reported, citing sources. Hyderabad-based Bharat Biotech submitted data on Friday, they added.
It looks like they should be able to approve it with additional data else they might have rejected last week itself.
Does anyone know what is going on here? Why is it sudden sell-off? I do not think that WHO can reject it since countries are allowing their vaccine before their approval. I believe it should go up from here.
Another coverage.
Raymond James analyst Elliot Wilbur maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Outperform and raises the price target from $60 to $65.
I told you yesterday that there will be coverage.
Ocugen Partner Bharat Biotech's Covaxin Recognized by Guyana for Travellers
https://www.livemint.com/news/india/bharat-biotech-s-covaxin-recognised-by-guyana-for-travellers-11635838000996.html
WHO will not wait until tomorrow to approve it since countries started to recognize Covaxin.
It might come by tomorrow morning if they have submitted requested details last week. Since they have decided to approve it then all paper work they might have done it when they ask for more details.
Going up in after hours. Tomorrow will be fun.
What do you guys think? Will it go up from here? I am thinking there might be upgrade from analyst after today's conference call and FDA approval news. You might see analyst upgrade with target price tomorrow.
once, it cross 5 then it going to go up fast. Target is to close above 6 today
IFRX - Entire float has been traded. It might get crazy soon.
Entire float has been traded. It might get crazy soon.
Nice reversal. It might close above $5 today.
Positive data, $50M grant, Analyst upgrade of strong buy with $14 target, More coming. No offering needed since they just got 50M from government(free money that they do not need to return). It is going north from this point forward.
NEW going up. It's going to close above $1 and up tomorrow.
This is day 1 only. You never know people might be chasing tomorrow to cover it.
Does anyone knows what is float and outstanding shares?
After hour is rocking like Friday. There will be bigggggg gap tomorrow.
Holding nicely @3.30. This has to close above 3 to keep momentum going.